Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Advanced Cancer
NCT06001749Phase 2Active, not recruiting
- Start
- Sep 2024
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in pain. Started Sep 2024; status: active, not recruiting.
02
Drugs
psilocybin
03
Conditions
pain
Beyond the preview
Go deeper on NCT06001749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06001749.